Isnain, Sitti Farrah S.
HRN: 28-53-97 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/12/2026
07/19/2026
PO
2.5 ML
TID
INTESTINAL AMOEBIASIS
Checking Initial Appropriateness
07/12/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/12/2026
07/19/2026
IV
168MG
Q6
PCAP C
Checking Initial Appropriateness
07/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2026
07/20/2026
IV
70mg
Q8h
Amoebiasis
Checking Final Appropriateness
07/14/2026
CEFTRIAXONE 1G (VIAL)
07/14/2026
07/20/2026
IV
600mg
OD
PCAP C
Checking Final Appropriateness
07/19/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/19/2026
07/25/2026
IV
90mg
Q8
Intraabdominal Infection
Checking Final Appropriateness
07/19/2026
CEFTRIAXONE 1G (VIAL)
07/19/2026
07/25/2026
IV
740mg
OD
Intraabdominal Infection
Checking Final Appropriateness